Pharmaceutical Exporter to Tajikistan from India

Yes. Indian pharmaceutical companies can supply Tajikistan through the regulated import channel, provided the product and importer meet applicable registration, licensing, import permission, certification and customs requirements.

The Ministry of Health and Social Protection of Population has responsibility for pharmaceutical policy and state registration functions, while the Tajikistan Trade Portal identifies the relevant pharmaceutical activity licence and import permissions for importers.

Medicines intended for production, sale and use in Tajikistan are subject to state registration under the country's pharmaceutical framework. The exact route should be checked for the product and intended use.

The file varies by product and shipment but can include invoice, packing list, Certificate of Origin, COA, GMP evidence, regulatory certificates and destination import or product authorization documents.

Yes. Tajikistan's general labelling framework uses Tajik and Russian, and pharmaceutical package information should be checked against the exact registration and labelling requirements.

India reported US$58.12 million in total exports to Tajikistan in FY2025–26, with drug formulations and biologicals as a leading export product group. World Bank WITS data recorded US$33.77 million in Indian pharmaceutical-product exports to Tajikistan in 2024.

Yes, subject to product availability, registration status and the applicable Tajik import pathway. A commercial enquiry should include the INN or brand, dosage form, strength, quantity and registration position.

Ask for company and export credentials, product documentation, manufacturer quality evidence and confirmation that the proposed supply route can meet the Tajik importer's requirements before placing an order.